June 1, 2021 09:06 AM EDTUpdated 10:55 AM

Covid-19 roundup: Moderna submits vaccine for full approval; WHO unveils new Greek-based system for naming variants

Josh Sullivan

Zachary Brennan

Senior Editor

Moderna has initiated its BLA submission process with the FDA to license its Covid-19 vaccine in adults 18 and older, the company announced Tuesday. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Moderna submits vaccine for full approval; WHO unveils new Greek-based system for naming variants

Josh Sullivan

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Pfizer looking to sell hospital drugs unit — reports

AstraZeneca CEO reaffirms commitment to China following executive's detention

'Expertise is a real thing': FDA commissioner warns of political risk to agency

Merck, AstraZeneca tout Phase 3 win for cancer-turned-rare disease drug

Novartis pays $150M upfront to Schrödinger in new drug deal, ramps up software use

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?

Covid-19 roundup: Mod­er­na sub­mits vac­cine for full ap­proval; WHO un­veils new Greek-based sys­tem for nam­ing vari­ants

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Moderna submits vaccine for full approval; WHO unveils new Greek-based system for naming variants